Alnylam Pharmaceuticals
ALNY
#635
Rank
โ‚น2.733 T
Marketcap
โ‚น21,116
Share price
0.52%
Change (1 day)
71.76%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company